Reinforcement of cell-mediated immunity driven by tumor-associated Epstein-Barr virus (EBV)-specific T cells during targeted B-cell therapy with rituximab

S Tischer-Zimmermann, A Bonifacius, M M Santamorena, P Mausberg, S Stoll, M Döring, U Kalinke, R Blasczyk, B Maecker-Kolhoff, B Eiz-Vesper